Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial

被引:2
|
作者
Toole, JF
Malinow, MR
Chambless, LE
机构
关键词
D O I
10.1016/j.jvs.2004.03.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:1356 / 1356
页数:1
相关论文
共 50 条
  • [1] Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
    Toole, JF
    Malinow, MR
    Chambless, LE
    Spence, JD
    Pettigrew, LC
    Howard, VJ
    Sides, EG
    Wang, CH
    Stampfer, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05): : 565 - 575
  • [2] Homocysteine-Lowering Therapy and Risk of Recurrent Stroke, Myocardial Infarction and Death: The Impact of Age in the VISP Trial
    Towfighi, Amytis
    Arshi, Baback
    Markovic, Daniela
    Ovbiagele, Bruce
    CEREBROVASCULAR DISEASES, 2014, 37 (04) : 263 - 267
  • [3] Plasma Aβ, homocysteine, and cognition The Vitamin Intervention for Stroke Prevention (VISP) trial
    Viswanathan, A.
    Raj, S.
    Greenberg, S. M.
    Stampfer, M.
    Campbell, S.
    Hyman, B. T.
    Irizarry, M. C.
    NEUROLOGY, 2009, 72 (03) : 268 - 272
  • [4] Vitamin Intervention for Stroke Prevention (VISP)
    不详
    STROKE, 2004, 35 (06) : E172 - E173
  • [5] Sex Differences in Genetic Associations with Homocysteine in the Vitamin Intervention for Stroke Prevention (VISP) Trial
    Elkhatib, Stacey D.
    Hsu, Fang-Chi
    Pemberton, Bradley L.
    Sale, Michele M.
    Worrall, Bradford B.
    STROKE, 2011, 42 (03) : E187 - E187
  • [6] Vitamin intervention for stroke prevention (VISP) trial: Rationale and design
    Spence, JD
    Howard, VJ
    Chambless, LE
    Malinow, MR
    Pettigrew, LC
    Stampfer, M
    Toole, JF
    NEUROEPIDEMIOLOGY, 2001, 20 (01) : 16 - 25
  • [7] Investigation of Recurrent Stroke Risk in the Vitamin Intervention for Stroke Prevention (VISP) Trial Suggests Different Genetic Influences on Prevalent and Incident Stroke
    Patel, Rohan K.
    Elias, Gustavo A.
    Hsu, Fang-Chi
    Mychaleckyj, Josyf C.
    Chen, Wei-Min
    Worrall, Bradford B.
    Sale, Michele M.
    STROKE, 2010, 41 (04) : E335 - E335
  • [8] Impact and Interaction of Low Estimated GFR and B Vitamin Therapy on Prognosis Among Ischemic Stroke Patients: The Vitamin Intervention for Stroke Prevention (VISP) Trial
    Lee, Meng
    Markovic, Daniela
    Ovbiagele, Bruce
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (01) : 52 - 57
  • [9] Screening of plasma homocyst(e)ine levels in stroke patients for the vitamin intervention for stroke prevention (VISP) clinical trial
    Malinow, MR
    Chambless, LE
    Howard, VJ
    Toole, JE
    STROKE, 1999, 30 (01) : 258 - 258
  • [10] Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients
    Feng, Wuwei
    Hendry, Robert M.
    Adams, Robert J.
    NEUROLOGY, 2010, 74 (07) : 588 - 593